Capstone Therapeutics's total assets for Q4 2024 were $47.22M, a decrease of -8.37% from the previous quarter. CAPS total liabilities were $50.28M for the fiscal quarter, a -5.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.